A few months ago, I blogged about Prof. Brian Quinn’s suggestion that new Section 122(18) of the DGCL might permit a Delaware corporation to adopt a “dead hand” poison pill. These pills were invalidated by the Delaware courts in the late 1990s, in part because they were inconsistent with the board’s authority to manage the business and […]